Baxter International (BAX) Competitors $27.68 -0.70 (-2.47%) As of 01:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BAX vs. EW, RMD, IDXX, DXCM, STE, PODD, HOLX, GMED, MASI, and TFXShould you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Globus Medical (GMED), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Baxter International vs. Edwards Lifesciences ResMed IDEXX Laboratories DexCom STERIS Insulet Hologic Globus Medical Masimo Teleflex Baxter International (NYSE:BAX) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability. Which has better earnings & valuation, BAX or EW? Edwards Lifesciences has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBaxter International$10.64B1.37-$649M-$1.28-22.13Edwards Lifesciences$5.44B7.55$4.17B$6.9710.02 Does the media prefer BAX or EW? In the previous week, Edwards Lifesciences had 26 more articles in the media than Baxter International. MarketBeat recorded 34 mentions for Edwards Lifesciences and 8 mentions for Baxter International. Edwards Lifesciences' average media sentiment score of 1.32 beat Baxter International's score of 0.72 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Edwards Lifesciences 25 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, BAX or EW? Baxter International has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Is BAX or EW more profitable? Edwards Lifesciences has a net margin of 72.93% compared to Baxter International's net margin of -5.05%. Edwards Lifesciences' return on equity of 19.40% beat Baxter International's return on equity.Company Net Margins Return on Equity Return on Assets Baxter International-5.05% 16.67% 4.93% Edwards Lifesciences 72.93%19.40%14.37% Do institutionals and insiders believe in BAX or EW? 90.2% of Baxter International shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 1.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor BAX or EW? Edwards Lifesciences received 600 more outperform votes than Baxter International when rated by MarketBeat users. Likewise, 70.82% of users gave Edwards Lifesciences an outperform vote while only 65.69% of users gave Baxter International an outperform vote. CompanyUnderperformOutperformBaxter InternationalOutperform Votes73765.69% Underperform Votes38534.31% Edwards LifesciencesOutperform Votes133770.82% Underperform Votes55129.18% Do analysts rate BAX or EW? Baxter International currently has a consensus target price of $38.56, indicating a potential upside of 36.09%. Edwards Lifesciences has a consensus target price of $78.55, indicating a potential upside of 12.44%. Given Baxter International's stronger consensus rating and higher probable upside, equities research analysts clearly believe Baxter International is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baxter International 1 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.40Edwards Lifesciences 1 Sell rating(s) 13 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.38 SummaryEdwards Lifesciences beats Baxter International on 14 of the 18 factors compared between the two stocks. Remove Ads Get Baxter International News Delivered to You Automatically Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BAX vs. The Competition Export to ExcelMetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$14.53B$4.09B$5.35B$18.51BDividend Yield2.21%39.52%5.11%4.25%P/E Ratio-22.1327.6221.7631.06Price / Sales1.3746.52376.0426.47Price / Cash6.4551.0838.1517.54Price / Book1.705.816.444.29Net Income-$649M$67.09M$3.20B$1.02B7 Day Performance1.32%5.35%6.18%6.63%1 Month Performance-18.22%-3.99%-8.80%-6.86%1 Year Performance-29.25%13.12%9.73%1.19% Baxter International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BAXBaxter International4.5561 of 5 stars$27.68-2.5%$38.56+39.3%-29.8%$14.20B$10.64B-21.6360,000EWEdwards Lifesciences4.5146 of 5 stars$69.25-0.2%$79.95+15.5%-22.6%$40.71B$5.44B9.9417,300Insider TradeNews CoveragePositive NewsRMDResMed4.4082 of 5 stars$212.97+3.8%$249.73+17.3%+15.4%$31.28B$4.93B25.148,160Analyst RevisionPositive NewsIDXXIDEXX Laboratories4.8063 of 5 stars$382.15-2.9%$533.75+39.7%-18.7%$30.97B$3.90B35.8110,800Analyst DowngradePositive NewsHigh Trading VolumeDXCMDexCom4.9082 of 5 stars$61.23+2.3%$99.82+63.0%-50.5%$23.94B$4.03B42.707,600Positive NewsSTESTERIS4.5518 of 5 stars$212.610.0%$258.75+21.7%+9.9%$20.86B$5.40B45.0716,000Positive NewsPODDInsulet4.5762 of 5 stars$254.88+3.9%$292.06+14.6%+45.8%$17.90B$2.07B44.022,600Short Interest ↓Positive NewsHOLXHologic4.8253 of 5 stars$61.07+0.3%$84.62+38.6%-23.9%$13.70B$4.04B19.266,940Positive NewsGMEDGlobus Medical4.7669 of 5 stars$70.22+2.0%$97.09+38.3%+41.3%$9.66B$2.52B93.632,600Short Interest ↑News CoveragePositive NewsMASIMasimo4.3874 of 5 stars$151.62+5.0%$194.80+28.5%+11.4%$8.19B$2.09B104.536,200TFXTeleflex4.3967 of 5 stars$130.63-1.0%$182.63+39.8%-38.4%$6.06B$3.05B25.9715,500 Remove Ads Related Companies and Tools Related Companies EW Competitors RMD Competitors IDXX Competitors DXCM Competitors STE Competitors PODD Competitors HOLX Competitors GMED Competitors MASI Competitors TFX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BAX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BAX Stock Free BAX Stock Alerts